Actinium Pharmaceuticals, Inc. / Estimates

    Fiscal Year Revenue Net income Net margin Free cash flow FCF margin
    (estimated) €16.55M +50.3% -€38.22M +14.1% -231.0% +0.73 pp N/A N/A
    (estimated) €11.01M +∞% -€33.49M -12.2% -304.1% -3.0 pp N/A N/A
    (estimated) €0.00 +NaN% -€38.12M +16.9% N/A N/A N/A
    €0.00 -100.0% -€32.62M -21.7% N/A -€28.20M -29.9% N/A
    €69.09K -92.1% -€41.64M +47.9% -60,269.1% -570 pp -€40.24M -623.7% -58,249.4% -590 pp
    €878.54K -10.0% -€28.16M +34.3% -3,205.5% -11 pp €7.69M -143.5% 874.8% +27 pp
    €975.78K +∞% -€20.97M +11.6% -2,149.0% -21 pp -€17.68M -3.0% -1,812.3% -18 pp
    €0.00 +NaN% -€18.80M +1.4% N/A -€18.22M -0.2% N/A
    €0.00 +NaN% -€18.53M -8.1% N/A -€18.25M +4.5% N/A
    €0.00 +NaN% -€20.18M -11.1% N/A -€17.46M -4.9% N/A
    €0.00 +NaN% -€22.69M +9.4% N/A -€18.36M +3.9% N/A
    €0.00 +NaN% -€20.75M +15.7% N/A -€17.68M +12.1% N/A
    €0.00 +NaN% -€17.93M -14.8% N/A -€15.78M +30.3% N/A
    €0.00 +NaN% -€21.06M +129.1% N/A -€12.11M +126.2% N/A
    €0.00 +NaN% -€9.19M +28.9% N/A -€5.35M +20.4% N/A
    €0.00 +NaN% -€7.13M -81,361.5% N/A -€4.44M -966,769.9% N/A
    €0.00 +NaN% €8.78K +514.6% N/A €459.74 -93.1% N/A
    €0.00 +NaN% €1.43K -107.5% N/A €6.68K -141.7% N/A
    €0.00 +NaN% -€19.05K -28.5% N/A -€16.02K +34.5% N/A
    €0.00 +NaN% -€26.65K +111.1% N/A -€11.91K -9.9% N/A
    €0.00 +NaN% -€12.62K -19.6% N/A -€13.21K +10.4% N/A
    €0.00 -€15.70K N/A -€11.97K N/A

    Notifications